{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:38:39Z","timestamp":1770223119690,"version":"3.49.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplant (HSCT) recipients remain highly susceptible to pneumococcal infection despite current vaccination strategies, and the contribution of T-cell\u2013mediated immunity to protection in this population is not fully defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a prospective study evaluating humoral and cellular immune responses to sequential pneumococcal vaccination with the 13-valent conjugate vaccine (PCV13) followed by the 23-valent polysaccharide vaccine (PPV23) in allogeneic HSCT recipients. Immune responses were assessed through serotype-specific antibody quantification, CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell proliferation assays, and cytokine profiling after\n                      <jats:italic>in vitro<\/jats:italic>\n                      stimulation with heat-killed\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Conjugate vaccination induced antigen-specific CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell proliferation and established T-cell memory. However, subsequent polysaccharide vaccination did not enhance CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell proliferation in sequentially vaccinated patients. PPV23 administration was associated with a decline in antibody titers for serotypes shared with the conjugate vaccine, while humoral responses to non-shared serotypes were preserved. Despite the lack of cellular boosting, the sequential schedule elicited a strong T-helper 17 cytokine response, characterised by increased secretion of interleukin-17A, interleukin-17F, and interleukin-22, suggesting activation of a pro-inflammatory pathway rather than expansion of functional immune memory.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study provides, to our knowledge, the first integrated analysis of both humoral and T-cell immune responses to pneumococcal vaccination in allogeneic HSCT recipients, offering a translational perspective that links immunological mechanisms with clinical relevance. Our findings indicate that conjugate vaccination is essential for priming both cellular and humoral immunity, whereas polysaccharide boosting primarily broadens serotype coverage but may attenuate previously established immune responses. In the context of emerging higher-valency conjugate vaccines, including the recently introduced 21-valent formulation incorporating novel serotypes, these results support a reassessment of the need for polysaccharide boosters and inform optimisation of pneumococcal vaccination strategies in immunocompromised hosts at high risk for invasive disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1724326","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:34:57Z","timestamp":1770183297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated analysis of humoral and T-cell responses to pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients"],"prefix":"10.3389","volume":"13","author":[{"given":"Andr\u00e9","family":"Silva-Pinto","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, S\u00e3o Jo\u00e3o University Hospital","place":["Porto, Portugal"]},{"name":"Host-Parasite Interactions, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o para a Sa\u00fade (i3S)","place":["Porto, Portugal"]},{"name":"Medicine Department, Faculty of Medicine of the University of Porto","place":["Porto, Portugal"]}]},{"given":"Ana Isabel","family":"Pinto","sequence":"additional","affiliation":[{"name":"Host-Parasite Interactions, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o para a Sa\u00fade (i3S)","place":["Porto, Portugal"]},{"name":"Immunohemotherapy Laboratory, Unidade Local de Sa\u00fade do Alto Ave","place":["Guimar\u00e3es, Portugal"]}]},{"given":"Pedro","family":"Curto","sequence":"additional","affiliation":[{"name":"Host-Parasite Interactions, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o para a Sa\u00fade (i3S)","place":["Porto, Portugal"]}]},{"given":"Joana","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Host-Parasite Interactions, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o para a Sa\u00fade (i3S)","place":["Porto, Portugal"]},{"name":"Biological Sciences Department, Faculty of Pharmacy, University of Porto","place":["Porto, Portugal"]}]},{"given":"Ricardo","family":"Pinto","sequence":"additional","affiliation":[{"name":"Medicine Department, Faculty of Medicine of the University of Porto","place":["Porto, Portugal"]},{"name":"Clinic Haematology Department, S\u00e3o Jo\u00e3o University Hospital","place":["Porto, Portugal"]}]},{"given":"Juliana","family":"Bastos","sequence":"additional","affiliation":[{"name":"Medicine Department, Faculty of Medicine of the University of Porto","place":["Porto, Portugal"]},{"name":"Clinic Haematology Department, S\u00e3o Jo\u00e3o University Hospital","place":["Porto, Portugal"]}]},{"given":"Lurdes","family":"Santos","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, S\u00e3o Jo\u00e3o University Hospital","place":["Porto, Portugal"]},{"name":"Medicine Department, Faculty of Medicine of the University of Porto","place":["Porto, Portugal"]}]},{"given":"Joana","family":"Tavares","sequence":"additional","affiliation":[{"name":"Host-Parasite Interactions, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o para a Sa\u00fade (i3S)","place":["Porto, Portugal"]},{"name":"Molecular Biology Department, Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, University of Porto","place":["Porto, Portugal"]}]},{"given":"Anabela","family":"Cordeiro-da-Silva","sequence":"additional","affiliation":[{"name":"Host-Parasite Interactions, Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o para a Sa\u00fade (i3S)","place":["Porto, Portugal"]},{"name":"Biological Sciences Department, Faculty of Pharmacy, University of Porto","place":["Porto, Portugal"]}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: Guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/154.4.590","article-title":"Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine","volume":"154","author":"Giebink","year":"1986","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2141.2002.03457.x","article-title":"Early and late invasive pneumococcal infection following stem cell transplantation: a European bone marrow transplantation survey","volume":"117","author":"Engelhard","year":"2002","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/md.0b013e31803eb176","article-title":"Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989\u20132005","volume":"86","author":"Youssef","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12320","article-title":"Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults","volume":"19","author":"Durando","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tim.2009.12.001","article-title":"Potential role for mucosally active vaccines against pneumococcal pneumonia","volume":"18","author":"Jambo","year":"2010","journal-title":"Trends Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41590-018-0231-y","article-title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus","volume":"19","author":"Jochems","year":"2018","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7010018","article-title":"Complementary role of CD4+ T cells in response to pneumococcal polysaccharide vaccines in humans","volume":"7","author":"Jha","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/j.1462-5822.2005.00591.x","article-title":"Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens","volume":"7","author":"Cobb","year":"2005","journal-title":"Cell Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide processing and presentation by the MHCII pathway","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged >\/=19 years: recommendations of the advisory committee on immunization practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3390\/vaccines12121449","article-title":"Vaccination after haematopoietic stem cell transplant: a review of the literature and proposed vaccination protocol","volume":"12","author":"Silva-Pinto","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the advisory committee on immunization practices - United States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12879-018-3341-0","article-title":"Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries","volume":"18","author":"Yahiaoui","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref16","year":"2025"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1016\/j.vaccine.2010.01.025","article-title":"Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial","volume":"28","author":"Cordonnier","year":"2010","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/infdis\/jiy135","article-title":"Immunogenicity and immunological memory induced by the 13-valent pneumococcal conjugate followed by the 23-valent polysaccharide vaccine in HIV-infected adults","volume":"218","author":"Farmaki","year":"2018","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O'Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.vaccine.2011.11.022","article-title":"Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections","volume":"30","author":"Hor\u00e1cio","year":"2012","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e73704","DOI":"10.1371\/journal.pone.0073704","article-title":"The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5","volume":"8","author":"Hor\u00e1cio","year":"2013","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41598-018-36799-x","article-title":"Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012\u20132015)","volume":"9","author":"Silva-Costa","year":"2019","journal-title":"Sci Rep"},{"key":"ref24","volume-title":"Programa Nacional de Vacina\u00e7\u00e3o 2020","author":"Freitas","year":"2020"},{"key":"ref25","volume-title":"Training manual for enzyme-linked immunosorbent assay for the quantitation of","year":""},{"key":"ref26","doi-asserted-by":"publisher","first-page":"739.e1","DOI":"10.1016\/j.cmi.2016.05.021","article-title":"Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic","volume":"22","author":"Ibarra-Meneses","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/infdis\/jix090","article-title":"Reduced T-helper 17 responses to Streptococcus pneumoniae in infection-prone children can be rescued by addition of innate cytokines","volume":"215","author":"Basha","year":"2017","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.trsl.2013.07.005","article-title":"Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus","volume":"163","author":"Martinez","year":"2014","journal-title":"Transl Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.actatropica.2013.04.002","article-title":"A whole blood assay as a simple, broad assessment of cytokines and chemokines to evaluate human immune responses to Mycobacterium tuberculosis antigens","volume":"127","author":"Silva","year":"2013","journal-title":"Acta Trop"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cyto.b.21165.","article-title":"Establishment of a healthy human range for the whole blood 'OX40' assay for the detection of antigen-specific CD4+ T cells by flow cytometry","volume":"86","author":"Sadler","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1586\/erv.11.8","article-title":"Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines","volume":"10","author":"Poolman","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1016\/j.vaccine.2012.03.082","article-title":"Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country","volume":"30","author":"Lundgren","year":"2012","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jleuko\/qiad070","article-title":"Neutrophil responsiveness to IL-10 impairs clearance of Streptococcus pneumoniae from the lungs","volume":"115","author":"Horn","year":"2024","journal-title":"J Leukoc Biol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1172\/JCI128865","article-title":"Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization","volume":"129","author":"Jochems","year":"2019","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"ofae220","DOI":"10.1093\/ofid\/ofae220","article-title":"Immunogenicity of current and next-generation pneumococcal conjugate vaccines in children: current challenges and upcoming opportunities","volume":"11","author":"Feemster","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/imm.12486","article-title":"Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae","volume":"146","author":"Penaloza","year":"2015","journal-title":"Immunology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/21645515.2015.1087625","article-title":"Rationale and prospects for novel pneumococcal vaccines","volume":"12","author":"Moffitt","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.bmt.1702","article-title":"Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine","volume":"27","author":"Parkkali","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2545032","DOI":"10.1080\/21645515.2025.2545032","article-title":"Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure","volume":"21","author":"Ganaie","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/jac\/dkaf085","article-title":"Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-21","volume":"80","author":"Schellenberg","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1724326\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:34:58Z","timestamp":1770183298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1724326\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":44,"alternative-id":["10.3389\/fmed.2026.1724326"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1724326","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1724326"}}